Wavelet Medical Secures $7M Seed to Advance AI-Powered Fetal Brain Monitoring
Summary
Wavelet Medical, a Yale University spinout, raised $7 million in seed funding led by Aegis Ventures to develop the first non-invasive, AI-powered fetal electroencephalography (EEG) monitoring platform. The technology uses sensors placed on the mother's abdomen with proprietary AI algorithms to reconstruct fetal EEG signals and identify auditory-evoked brain responses indicating neurological distress in real time.
Why it matters
Wavelet's technology represents a paradigm shift from fetal heart rate monitoring to direct fetal brain activity assessment, potentially enabling earlier detection of hypoxia and reducing unnecessary C-sections. With over 140 million births annually worldwide, the technology addresses a massive unmet need in maternal-fetal medicine.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial